Yoon Jun has filed 16 insider transactions across 1 company since February 2023.
Most recent transaction: a grant/award of 104085 shares of Structure Therapeutics Inc. ($GPCR) on March 19, 2026.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 19, 2026 | Structure Therapeutics Inc. | $GPCR | Yoon Jun | CHIEF FINANCIAL OFFICER | A | Ordinary Shares | 104085 | $0.00 | 2,956,242.0000 | 177,596,000 | 3.65% | 0.06% |
| March 19, 2026 | Structure Therapeutics Inc. | $GPCR | Yoon Jun | CHIEF FINANCIAL OFFICER | A | Employee Stock Option (right to buy) | 128892 | $0.00 | 128,892.0000 | 177,596,000 | 9999.99% | 0.07% |
| March 3, 2026 | Structure Therapeutics Inc. | $GPCR | Yoon Jun | CHIEF FINANCIAL OFFICER | F | Ordinary Shares | 22305 | $20.99 | 2,852,157.0000 | 177,596,000 | 0.78% | 0.01% |
| May 21, 2025 | Structure Therapeutics Inc. | $GPCR | Yoon Jun | CHIEF FINANCIAL OFFICER | A | American Depositary Shares | 831 | $0.00 | 2,946.0000 | 172,051,000 | 39.29% | 0.00% |
| March 1, 2025 | Structure Therapeutics Inc. | $GPCR | Yoon Jun | CHIEF FINANCIAL OFFICER | F | Ordinary Shares | 5940 | $7.92 | 2,841,945.0000 | 157,922,000 | 0.21% | 0.00% |
| July 1, 2025 | Structure Therapeutics Inc. | $GPCR | Yoon Jun | CHIEF FINANCIAL OFFICER | F | Ordinary Shares | 7089 | $6.84 | 2,874,462.0000 | 172,351,000 | 0.25% | 0.00% |
| July 1, 2025 | Structure Therapeutics Inc. | $GPCR | Yoon Jun | CHIEF FINANCIAL OFFICER | A | Ordinary Shares | 39606 | $0.00 | 2,881,551.0000 | 172,351,000 | 1.39% | 0.02% |
| Nov. 20, 2024 | Structure Therapeutics Inc. | $GPCR | Yoon Jun | CHIEF FINANCIAL OFFICER | A | American Depositary Shares | 821 | $0.00 | 2,115.0000 | 171,630,000 | 63.45% | 0.00% |
| March 15, 2025 | Structure Therapeutics Inc. | $GPCR | Yoon Jun | CHIEF FINANCIAL OFFICER | A | Ordinary Shares | 170166 | $0.00 | 2,847,885.0000 | 157,922,000 | 6.35% | 0.11% |
| March 15, 2025 | Structure Therapeutics Inc. | $GPCR | Yoon Jun | CHIEF FINANCIAL OFFICER | A | Employee Stock Option (right to buy) | 413445 | $0.00 | 413,445.0000 | 157,922,000 | 9999.99% | 0.26% |
| May 20, 2024 | Structure Therapeutics Inc. | $GPCR | Yoon Jun | CHIEF FINANCIAL OFFICER | A | American Depositary Shares | 694 | $0.00 | 1,294.0000 | 139,710,000 | 115.67% | 0.00% |
| March 15, 2024 | Structure Therapeutics Inc. | $GPCR | Yoon Jun | CHIEF FINANCIAL OFFICER | A | Stock Option (right to buy) | 148134 | $0.00 | 148,134.0000 | 110,198,000 | 9999.99% | 0.13% |
| March 15, 2024 | Structure Therapeutics Inc. | $GPCR | Yoon Jun | CHIEF FINANCIAL OFFICER | A | Ordinary Shares | 59469 | $0.00 | 2,677,719.0000 | 110,198,000 | 2.27% | 0.05% |
| March 15, 2024 | Structure Therapeutics Inc. | $GPCR | Yoon Jun | CHIEF FINANCIAL OFFICER | A | Stock Option (right to buy) | 148134 | $0.00 | 148,134.0000 | 110,198,000 | 9999.99% | 0.13% |
| Feb. 7, 2023 | Structure Therapeutics Inc. | $GPCR | Yoon Jun | Chief Financial Officer | P | American Depositary Shares | 600 | $15.00 | 600.0000 | 9,584,000 | 9999.99% | 0.01% |
| Feb. 2, 2023 | Structure Therapeutics Inc. | $GPCR | Yoon Jun | Chief Financial Officer | A | Stock option (right to buy) | 750000 | $0.00 | 750,000.0000 | 9,584,000 | 9999.99% | 7.83% |